Skip to main content

Month: August 2020

American Energy Partners Subsidiary Awarded U.S. Patent

ALLENTOWN, PA, Aug. 04, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — American Energy Partners, Inc. (“American Energy”) (PINK: AEPT), a diversified energy company, announces that its subsidiary Hydration Company of PA, LLC (“Hydration”) has been awarded a utility patent from the U.S. Patent and Trademark Office (“USPTO”). The USPTO issued U.S. Pat. No. 10,730,760 on August 4, 2020. American Energy, parent to Hydration, has retained the accounting and consulting firm Grossman Yanak & Ford, LLP. The firm specializes in the valuation of intellectual property and we expect to receive a valuation on the patent prior to Q4 ‘20. The following is a link to the USPTO website for further information on our newly issued patent: USPTO Website.Brad Domitrovitsch, Chairman & CEO of American Energy, stated, “After several years of...

Continue reading

Marrone Bio Innovations to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th

DAVIS, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place August 11 to 13, 2020.Jim Boyd, Chief Financial Officer, is scheduled to host a virtual presentation during the conference and will also participate in virtual one-on-one meetings throughout the day with Chief Executive Officer Kevin Helash.Canaccord Genuity 40th Annual Growth ConferenceDate:     Wednesday, August 12, 2020Time:     4:30 p.m. Eastern time (1:30 p.m. Pacific Time)Webcast Link:    http://wsw.com/webcast/canaccord42/mbii/For more information...

Continue reading

Ultragenyx to Present at Upcoming Investor Conferences

NOVATO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will hold virtual presentations at the following upcoming investor conferences:Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will hold a virtual presentation at the Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2020 at 2:55 PM ET. Shalini Sharp, the company’s Chief Financial Officer, will hold a virtual presentation at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020 at 2:00 PM ET.The live and archived webcast of the presentation will be accessible from the company’s website...

Continue reading

Festi hf.: Publication of Q2 2020 results on Thursday 6 August 2020

Festi will publish the Q2 2020 results on Thursday 6 August 2020 after the closure of markets. A presentation meeting will be held on Friday 7 August 2020 at Dalvegur 10-14, Kópavogur, the company´s headquarters. Eggert Kristófersson CEO of Festi will present the results and answer questions.The meeting will begin at 08:30 local time. Refreshments will be available from 08:00.The presentation and related material will be accessible on Festi‘s website following the online presentation, see www.festi.is/fjarfestatengsl

Continue reading

UPP Olaines OÜ consolidated unaudited financial results for Q2 and 6 months of 2020

Management commentary for the 6 months of 2020Net rental income was 1 308 860 euros for the 6 months of 2020 (2019 6 months: 1 291 518). Operating profit was 1 228 236 euros for the 6 months of 2020 (2019 6 months: 1 244 800). Net income was 627 652 euros for the 6 months of 2020 (2019 6 months: 454 710).The company’s sole business activity is to collect rental revenue, manage the Olaine property and service its liabilities to lenders and investors. Liabilities include the subordinated bonds with a fixed interest rate and the investment loan which’ rate is also fixed with an interest rate swap agreement. On the revenue side the company earns stable triple-net rental income from reputable tenants, which is fixed with medium-term agreements but is subject to indexation. Due to the economically fixed nature of the company, there needs to...

Continue reading

Recruiter.com Partners with DVBE Connect to Curate Team of Veteran Recruiters

HOUSTON, Aug. 04, 2020 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), a leading hiring platform with the world’s largest network of recruiters, has announced a partnership with DVBE Connect (“DVBE”) to build a curated on-demand team of veteran recruiters. DVBE is an award-winning, disabled veteran-owned recruiting and staffing company.Recruiter.com allows any employer to easily add recruiters to their talent acquisition team to get them through a period of fast-growth and hiring, with simple, flat monthly pricing and no success fees.“As a leading recruiting provider to national insurance companies and the healthcare IT market, we are seeing more and more companies seek to utilize disabled veterans as their recruiting and staffing source,” said Chris Haney, Founder, and CEO of DVBE. “By partnering...

Continue reading

America First Multifamily Investors, L.P. Announces Second Quarter 2020 Financial Results

OMAHA, Neb., Aug. 04, 2020 (GLOBE NEWSWIRE) — On August 4, 2020, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership” or “ATAX”) announced financial results for the three and six months ended June 30, 2020.Financial HighlightsAs of and for the three months ended June 30, 2020:Total revenues of approximately $14.5 millionNet income, basic and diluted, of $0.06 per Beneficial Unit Certificate (“BUC”)Cash Available for Distribution of $0.09 per BUCTotal assets of approximately $1.0 billionTotal Mortgage Revenue Bond (“MRB”) investments of approximately $787.6 millionFor the six months ended June 30, 2020:Total revenues of approximately $28.2 millionNet income, basic and diluted, of $0.10 per BUCCash Available for Distribution of $0.14 per BUCThe Partnership reported the following notable transactions during the...

Continue reading

WisdomTree announces index change for WTI Crude Oil ETC

NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) — WisdomTree, an exchange traded fund (“ETF”) and exchange traded product (“ETP”) sponsor, has today announced a change to the underlying index tracked by WisdomTree WTI Crude Oil ETC (CRUD), following a vote by security holders. The index change was completed on August 4, 2020 and is exclusive to WisdomTree.The new index, the Bloomberg WTI Crude Oil Multi-Tenor Excess Return Index, is the result of extensive work between WisdomTree and Bloomberg to create an index which would be resilient to extreme conditions in the WTI Crude Oil market. The index aims to track the performance of an equal-weight basket of three WTI Crude Oil future contracts and is rebalanced monthly.Alexis Marinof, Head of Europe, WisdomTree, said: “CRUD is the largest and most liquid oil ETC in...

Continue reading

Cocrystal Pharma Announces the Publication by Collaborators of Positive Data Demonstrating Potent In Vitro Inhibition Against Coronavirus in Science Translational Medicine Journal

– Cocrystal has two exclusive licenses for the coronavirus protease inhibitors described in the publication –– Cocrystal is currently further conducting preclinical studies of these coronavirus protease inhibitors (3CL) –BOTHELL, WA, Aug. 04, 2020 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced the publication of preclinical animal studies of coronavirus antiviral compounds in the renowned medical journal, Science Translational Medicine.The manuscript titled, “The 3C-like protease inhibitors with potent in-vitro inhibition against SARS-CoV-2 and therapeutic efficacy in MERS-CoV infected mice,” was published online in the 3 August 2020 Science Translational Medicine Journal. Authors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.